HAEMOPHILIA PROGRAMMES LEAD SCIENTISTNEQAS BCSHEFFIELD, England, United Kingdom
PB1105 - Post-infusion monitoring of Afstyla FVIII replacement therapy – data from the UK National External Quality assessment for Blood Coagulation (UK NEQAS BC) programme 2022.
Tuesday, June 27, 202318:30 – 19:30 ET
PB1112 - UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Emicizumab programme, survey July 2022 results for modified one-stage assay and chromogenic assay.
